Log in to search using one of your social media accounts:

 

AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

AIDSinfo Releases HIV/AIDS Guidelines App for iOS and Android Devices
AIDSinfo is pleased to introduce HIV providers and other health professionals to our newly released HIV/AIDS Guidelines app! The AIDSinfo Guidelines app provides mobile access to the federally approved HIV/AIDS medical practice treatment guidelines. The guidelines include recommendations approved by expert panels on the treatment of HIV infection and related opportunistic infections in adults, adolescents, and children and on the management of perinatal HIV infection. Health care providers surveyed on the AIDSinfo website expect mobile access to up-to-date HIV information at the point of care—even when an Internet c...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 15, 2016 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from FDA and NIAID
From FDA: December 21, 2015: FDA Updates Blood Donor Deferral Policy to Reflect the Most Current Scientific Evidence and Continue to Ensure the Safety of the U.S. Blood Supply December 21, 2015: Final Guidance: “Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products” From NIAID: December 23, 2015: HIV Antibody Infusion Safely Suppresses Virus in Infected People (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 8, 2016 Category: Infectious Diseases Source Type: news

FDA Updates Saquinavir Labeling
“FDA approved changes to the Invirase (saquinavir mesylate) label to provide update[s] for drugs that are contraindicated or interact with Invirase/ritonavir." “Also a warning was added to state cobicistat is not recommended for concomitant use with Invirase.” The updated labeling will be available at the FDA website. More information is available: FDA: Press release AIDSinfo: Patient fact sheet on saquinavir (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 8, 2016 Category: Infectious Diseases Source Type: news

Community Member Nominations are Now Being Accepted for the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting nominations for a new community representative to serve a 4-year term beginning April 2016 with potential for reappointment for one additional term. Individuals who served as Panel members in the past are welcome to reapply. The Panel welcomes diversified representation in the community membership reflecting the demographics of the current HIV epidemic in the United States. The community member may assist the Panel in identifying and addressing unique treatment aspects that relate to the constituency he/she represents. The can...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 8, 2016 Category: Infectious Diseases Source Type: news

Scientific/Clinical Member Nominations are Now Being Accepted for the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting nominations for new scientific/clinical members with expertise in HIV medicine. The Panel is seeking candidates with expertise in any of the following areas of HIV clinical research and clinical care: adolescent medicine, biostatistics, HIV drug resistance, and hepatitis coinfection. Individuals who served as Panel members in the past are welcome to reapply. Panel members critically evaluate new information and prepare guidelines revisions. The candidates should be recognized experts in their areas of interest. The successf...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 8, 2016 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from CDC
December 7, 2015: New CDC Efforts Offer Individuals Vital Information to Reduce Personal HIV Risk December 6, 2015: HIV Diagnoses Decline Almost 20 Percent, but Progress Is Uneven December 6, 2015: Southern States Lag Behind Rest of Nation in HIV Treatment, Testing   (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 18, 2015 Category: Infectious Diseases Source Type: news

Updates to the Mucocutaneous Candidiasis and Syphilis Sections of the Adult and Adolescent OI Guidelines
Discussion of management of patients with sexual risk history is expanded in terms of diagnostic and therapeutic approaches. Recommendations for the diagnosis and management of neurosyphilis and ocular syphilis have been more extensively delineated. Updated recommendations for treatment and retreatment options for syphilis in non-pregnant and pregnant persons are also provided. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 18, 2015 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from CDC and NIAID
From CDC: November 24, 2015: New CDC Estimates Underscore the Need to Increase Awareness of a Daily Pill That Can Prevent HIV Infection From NIAID: December 1, 2015: NIH Scientists Draw Evidence-Based Blueprint for HIV Treatment and Prevention November 25, 2015: NIH Publishes Criteria for Research on Organ Transplantation Between People with HIV Infection (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 4, 2015 Category: Infectious Diseases Source Type: news

OAR Develops FY 2016 Trans-NIH Plan for HIV-Related Research
Each year the NIH Office of AIDS Research (OAR) develops a Trans-NIH Plan for HIV-Related Research. The plan identifies overarching HIV/AIDS research priorities and specific research objectives. The following key scientific priorities shape the FY 2016 Trans-NIH Plan for HIV-Related Research: Prevention research Research toward a cure Optimization of therapeutics Coinfections, comorbidities, and complications Basic research To learn more, visit the OAR website. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Hea...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 4, 2015 Category: Infectious Diseases Source Type: news

Adult and Adolescent ARV Guidelines: Survey
Do you utilize the HIV treatment guidelines? Your opinion is valuable! The Panel on Antiretroviral Guidelines for Adults and Adolescents and the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is committed to improving the Department of Health and Human Services (HHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. HAB has launched a survey (OMB clearance number 1090-0007) to receive feedback on experiences with the guidelines. The survey is open until December 18, 2015. The survey takes less than 15 minutes to complete, and all responses will remain ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 4, 2015 Category: Infectious Diseases Source Type: news

NIH Launches Initiative to Develop Long-Acting HIV Treatment and Prevention Tools
"The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, launched a major initiative to advance novel approaches to treat and prevent HIV infections based on broadly neutralizing antibodies (bNAbs) today. A public-private partnership has been established for this effort between NIAID and the global pharmaceutical company GlaxoSmithKline (GSK) to enable researchers to develop one or more bNAbs, which can stop a wide range of HIV strains from infecting human cells in the laboratory, into a product to treat or prevent HIV infection."   For more information, ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news

December 1 is World AIDS Day
December 1 is recognized globally as World AIDS Day. The annual observance highlights the remarkable advances in HIV prevention, treatment, and care since what became known as the AIDS epidemic was first reported three decades ago. World AIDS Day is also an occasion to reflect on the ongoing challenges to achieve an AIDS-free generation. Visit our World AIDS Day webpage [en español] to learn more about this observance and to find HIV/AIDS-related information and resources. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health a...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news

HRSA Launches Survey on Adult and Adolescent ARV Guidelines
The Panel on Antiretroviral Guidelines for Adults and Adolescents and the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is committed to improving the Department of Health and Human Services (HHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. HAB has launched a survey to receive feedback on experiences with the guidelines. The target audience are those staff that utilize the HIV treatment guidelines such as physicians, nurses, physician assistants (PAs), etc. It takes less than 15 minutes to complete the survey, and all responses will remain anonymous. ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Now Included Among Recommended Regimens for Antiretroviral Treatment-Naive Individuals with HIV-1 Infection
The FDA recently approved the fixed-dose combination of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (EVG/c/FTC/TAF) as a complete regimen for antiretroviral treatment (ART)-naive HIV-infected individuals 12 years or older. Based on efficacy and safety data from phase 3 randomized clinical trials, the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents will include EVG/c/FTC/TAF among the Recommended Initial Regimens for ART-naive adults and adolescents with estimated creatinine clearance ≥ 30 mL/min (AI). For more information, see the Panel’s statement on EVG/c/FTC/TAF. (Source...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news

FDA Announces Final Guidance: HIV-1 Infection: Developing Antiretroviral Drugs for Treatment: Guidance for Industry
FDA is announcing final guidance titled “Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment: Guidance for Industry.”   This guidance provides recommendations for the development of antiretroviral drugs regulated within the Center for Drug Evaluation and Research at the FDA for the treatment of human immunodeficiency virus-1 (HIV-1 or HIV) infection. Specifically, this guidance addresses the FDA’s current thinking regarding the overall development program and clinical trial designs for antiretroviral drugs to support an indication for the treatment of HIV-1 infecti...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2015 Category: Infectious Diseases Source Type: news

HRSA Launches Survey on Adult and Adolescent ARV Guidelines
The Panel on Antiretroviral Guidelines for Adults and Adolescents and the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is committed to improving the Department of Health and Human Services (HHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. HAB has launched a survey to receive feedback on experiences with the guidelines.  The target audience are those staff that utilize the HIV treatment guidelines such as physicians, nurses, physician assistants (PAs), etc. It takes less than 15 minutes to complete the survey, and all respon...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2015 Category: Infectious Diseases Source Type: news

Updates to the CMV (Herpes Virus) Section of the Adult OI Guidelines
This revision provides guidance for the management of cytomegalovirus (CMV) retinitis, which develops or worsens in the setting of ART initiation. Data supporting the treatment of CMV retinitis with systemic anti-CMV therapy for prevention of contralateral eye and visceral disease are discussed.   (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2015 Category: Infectious Diseases Source Type: news

FDA Approves Genvoya (a Fixed-Dose Combination Tablet) to Treat HIV Infection
“The U.S. Food and Drug Administration today [November 5, 2015] approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. …   “Genvoya is approved for use in HIV-infected adults and children ages 12 years and older weighing at least 35 kilograms (77 pounds) who have never taken HIV therapy (treatment-naïve) and HIV-infected adults whose HIV-1 virus is currently suppressed. While Genvoya is not recommended fo...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2015 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from HHS and NIAID
From HHS: October 21, 2015: HHS Awards $2.2 Billion in Grants for HIV/AIDS Care and Medications From NIAID: October 21, 2015: Immune Responses Provide Clues for HIV Vaccine Development October 20, 2015: HIV Cure Research: NIH Scientists Create Two-Headed Protein to Deplete HIV Reservoir (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 23, 2015 Category: Infectious Diseases Source Type: news

infoSIDA is on Twitter!
infoSIDA recently launched its own Spanish-language Twitter account. Previously, Spanish tweets would be posted on occasion on the @AIDSinfo Twitter account. Now, with its own account, infoSIDA will tweet daily to connect the Hispanic/Latino community with HIV/AIDS information. This account will provide followers with health tips and links to resources and news articles in Spanish. To view Spanish-language tweets about HIV/AIDS, follow @infoSIDA on Twitter today. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 23, 2015 Category: Infectious Diseases Source Type: news

Updated AIDSinfo Consumer Fact Sheets Offer an Overview of HIV
The updated AIDSinfo consumer fact sheets provide an introduction to HIV, including the basics of HIV prevention, transmission, and treatment. Each fact sheet includes a summary of key points and links to additional information. View or download the following updated fact sheets: The Basics of HIV Prevention HIV/AIDS: The Basics The HIV Life Cycle The Stages of HIV Infection HIV Testing HIV/AIDS Clinical Trials Visit infoSIDA to view the fact sheets in Spanish. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department o...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 23, 2015 Category: Infectious Diseases Source Type: news

Limited Access to Pyrimethamine Prompts Update of Toxoplasmosis Section of the Adult and Adolescent OI Guidelines
The Toxoplasma gondii Encephalitis section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents has been updated to provide clinicians with guidance on the use of trimethoprim-sulfamethoxazole for treatment of acute infection and chronic maintenance therapy for suspected or documented toxoplasmosis if pyrimethamine is not readily available.   On September 10, 2015, the OI Guidelines author panel issued this Notice of Availability of Pyrimethamine, which is guidance on what to do if pyrimethamine is unavailable to treat or prevent Toxoplasma encephalitis,...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 19, 2015 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from CDC and NIH
From CDC: September 30, 2015: CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines   From NIH: September 30, 2015: Drug Used to Treat HIV Linked to Lower Bone Mass in Newborns (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 9, 2015 Category: Infectious Diseases Source Type: news

October 15 is National Latino AIDS Awareness Day
. This observance serves to heighten awareness of the disproportionate burden of HIV among Hispanics/Latinos. According to the Centers for Disease Control and Prevention (CDC), the estimated new HIV infection rate among Hispanics/Latinos in 2010 in the United States was more than 3 times as high as that of whites.   Visit our National Latino AIDS Awareness Day webpage [en español] to learn more about HIV in the Hispanic/Latino population. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 9, 2015 Category: Infectious Diseases Source Type: news

FDA Updates Atazanavir Oral Powder Label
"On September 24, 2015, FDA approved revisions to the Reyataz (atazanavir) oral powder label to include dosing recommendations for patients three months and older weighing at least 5 kg. This represents the addition of a new pediatric weight band. Previously the oral powder formulation was for patients three months and older weighing at least 10 kg.   "Reyataz oral powder must be taken with ritonavir and is not recommended for use in children who weigh less than 5 kg."   The updated labeling will be available at the FDA website.   More information is available: FDA: Press release AIDSinfo...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 9, 2015 Category: Infectious Diseases Source Type: news

September 27 is National Gay Men’s HIV/AIDS Awareness Day
On September 27, join AIDSinfo in observing National Gay Men’s HIV/AIDS Awareness Day.   No group in the United States is more affected by HIV than gay and bisexual men. According to the Centers for Disease Control and Prevention (CDC), in 2013 in the United States, gay and bisexual men accounted for 65% of the 47,352 estimated HIV diagnoses among all people receiving an HIV diagnosis that year. In the same year, gay and bisexual men accounted for 55% of the estimated number of persons diagnosed with AIDS among all adults and adolescents in the United States.   Visit our National Gay Men’s HIV/AIDS Aw...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 25, 2015 Category: Infectious Diseases Source Type: news

NLM Releases Redesigned, Mobile-Optimized HIV/AIDS Information Website, Now Called AIDSource
The National Library of Medicine’s web portal for HIV/AIDS information has been redesigned and given a new name. The new website, AIDSource, offers access to a comprehensive collection of HIV/AIDS-related resources reviewed and selected by expert information specialists and librarians.   Visitors to the AIDSource website will now be able to view the website content on any device that they are using, as the website is now automatically optimized for display across all device types, including desktop computers, tablets, and smartphones. Feedback received through a website survey conducted in 2014 informed changes ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 25, 2015 Category: Infectious Diseases Source Type: news

Guideline Updates: Adult & Adolescent OI Guideline
Authors of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently released updates to the following sections: HPV - This update provides new recommendations regarding the cervical cancer screening interval for HIV-positive women after 3 consecutive normal Pap tests, and the use of HPV co-testing among HIV-positive  women>30 years of age. It additionally includes recommendations regarding the use of 9-valent HPV vaccine among HIV-positive females and males ages 9-26 to prevent HPV infection. HSV - This update provides new information rega...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 25, 2015 Category: Infectious Diseases Source Type: news

September 18 is National HIV/AIDS and Aging Awareness Day
The importance of National HIV/AIDS and Aging Awareness Day increases as the number of people aged 50 and older who are living with HIV continues to grow. According to the Centers for Disease Control and Prevention (CDC), people aged 55 and older accounted for 26% of the estimated 1.2 million people living with HIV infection in the United States in 2011.   Browse our National HIV/AIDS and Aging Awareness Day webpage [en español] to find resources and in-depth information about HIV and aging. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Ser...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 11, 2015 Category: Infectious Diseases Source Type: news

Availability of Pyrimethamine: Statement from Adult & Adolescent OI Guideline Panel
Pyrimethamine is recommended for treatment and/or prophylaxis of Toxoplasma encephalitis, Pneumocystis pneumonia, and Isospora infection. As of June 2015, pyrimethamine is no longer available in retail pharmacies in the United States. It is only available through a special pharmacy program (http://www.daraprimdirect.com/how-to-prescribe). If there is a delay in procuring pyrimethamine for a patient in whom it is needed for one of the above indications, please refer to the specific pathogen section for alternative drug regimens for treatment or prophylaxis. For patients with suspected or documented toxoplasmosis who do not ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 11, 2015 Category: Infectious Diseases Source Type: news

Creative and Novel Ideas in HIV Research (CNIHR) Research Grant Initiative
The NIH OAR, NIH CFARs, and International AIDS Society (IAS) have launched the fifth round of the Creative and Novel Ideas in HIV Research (CNIHR) research grant initiative. The concept proposals are due October 16, 2015. Since 2010, the CNIHR Program has awarded more than $16.1 million to fund 44 innovative research projects in the HIV field. The intent of this program is to attract both international and U.S.-based early-stage investigators from outside the field of HIV research to help address key scientific questions in HIV research, including emerging issues of long-term survival with HIV infection, prevention of HIV ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 11, 2015 Category: Infectious Diseases Source Type: news

FDA Updates Rilpivirine Labeling
"On August 26, 2015 the Edurant (rilpivirine) product labeling was updated to include the use of rilpivirine in combination with other antiretroviral agents for the treatment of HIV-1 infection to include treatment-naïve pediatric patients from 12 to less than 18 years of age with HIV-1 RNA less than or equal to 100,00 copies/mL. … In addition to the addition of the adolescent data to the label, changes were made the Warnings and Precautions with respect to Depressive Disorders and updates to the adrenal function subsection in section 6 Adverse Reactions."   The updated labeling will be available...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 28, 2015 Category: Infectious Diseases Source Type: news

Updates to the Adult and Adolescent Opportunistic Infections Guidelines
The Bacterial Enteric Infections section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents was recently updated. This update provides new data on ciprofloxacin resistance in Shigella sonnei and improved clinical success when Clostridium difficile infection (CDI) is treated with vancomycin. Limited data suggest fecal microbiota therapy for recurrent CDI may be safe and successful in HIV-infected patients.   (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 28, 2015 Category: Infectious Diseases Source Type: news

AIDSinfo Updates Consumer Fact Sheets on HIV and Women
The updated AIDSinfo consumer fact sheets offer information pertinent to women, including the use of HIV medicines to prevent mother-to-child transmission of HIV. Each fact sheet includes a summary of key points and links to additional information.   View or download the following fact sheets about HIV and women: HIV and Women Preventing Mother-to-Child Transmission of HIV The Use of HIV Medicines During Pregnancy Preventing Mother-to-Child Transmission of HIV During Childbirth Preventing Mother-to-Child Transmission of HIV After Birth Visit infoSIDA to view the fact sheets in Spanish. (Source: AIDSinfo At...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 28, 2015 Category: Infectious Diseases Source Type: news

Large Percentage of Youth with HIV May Lack Immunity to Measles, Mumps, Rubella
"Between one-third and one-half of individuals in the United States who were infected with HIV around the time of birth may not have sufficient immunity to ward off measles, mumps, and rubella—even though they may have been vaccinated against these diseases. This estimate, from a National Institutes of Health research network, in collaboration with the Centers for Disease Control and Prevention, is based on a study of more than 600 children and youth exposed to HIV in the womb."   To learn more, view the NIH press release. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Preve...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 14, 2015 Category: Infectious Diseases Source Type: news

FDA Updates Tivicay and Triumeq Labeling
"The Tivicay (dolutegravir) and Triumeq (abacavir/dolutegravir/lamivudine) product labeling was updated with drug-drug interaction information."   The updated labeling is available at the FDA website.   More information is available: FDA: Press release AIDSinfo: Patient fact sheet on Tivicay AIDSinfo: Patient fact sheet on Triumeq (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 14, 2015 Category: Infectious Diseases Source Type: news

Statement on NIH Efforts to Focus Research to End the AIDS Pandemic
Dr. Francis S. Collins, Director of the National Institutes of Health, has issued a statement outlining new high-priority areas of HIV/AIDS research. The research priorities are focused on advancing efforts to end the AIDS pandemic.   For more information, please see Dr. Collins’ statement. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 14, 2015 Category: Infectious Diseases Source Type: news

Updated AIDSinfo HIV/AIDS Glossary and Companion App Now Include Images
We are pleased to announce the release of the 8th edition of the AIDSinfo Glossary of HIV/AIDS-Related Terms and a redesign of the corresponding glossary app! This update features the addition of images and infographics highlighting select glossary terms. With definitions for more than 700 HIV/AIDS-related terms in English and Spanish, the glossary—whether online, in print, or as an app—offers a comprehensive guide to the vocabulary of HIV. The free glossary app, available for iOS and Android devices, has been redesigned with an updated look and feel. The app includes several new features that make it easy to ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 14, 2015 Category: Infectious Diseases Source Type: news

Updated HHS Perinatal Antiretroviral Treatment Guidelines Released
The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. For a complete preview of key updates to the guidelines, please see What's New in the Guidelines. Additions and revisions are also highlighted in yellow throughout the text and tables in the PDF version of the guidelines. To view or download the guidelines, go to the Perinatal Guidelines section of AIDSinfo. Sepa...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 6, 2015 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from NIAID
July 30, 2015: HVTN 505 Vaccine Induced Antibodies Nonspecific for HIV July 23, 2015: Two Paths Pave Way for Development of a Preventive HIV Vaccine July 21, 2015: Study Finds PrEP Use Feasible Among High-Risk Groups in U.S. Community Settings July 20, 2015: Dr. Fauci at IAS 2015: Comprehensive Global Prevention Can End HIV/AIDS Pandemic July 20, 2015: Early Antiretroviral Therapy Prevents Non-Aids Outcomes in HIV-Infected People, NIH-Supported Study Finds July 20, 2015: HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus July 20, 2015: Young South African Wom...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 31, 2015 Category: Infectious Diseases Source Type: news

FDA Approves Diagnostic Test to Differentiate Between Types of HIV Infection
"The U.S. Food and Drug Administration today [July 23, 2015] approved the Bio-Rad BioPlex 2200 HIV Ag-Ab assay, the first FDA-approved diagnostic that differentiates between HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigen in human serum or plasma specimens. …   "The Bio-Rad BioPlex 2200 HIV Ag-Ab assay is to aid in the diagnosis of infection with HIV-1 and/or HIV-2, including acute HIV-1 infection. It may be used in adults, children two years of age and older, as well as in pregnant women."   For more information, view the FDA news release. (Source: AIDSinfo At-a-Glance: Offering I...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 31, 2015 Category: Infectious Diseases Source Type: news

Updated National HIV/AIDS Strategy Released
The White House Office of National AIDS Policy has released the National HIV/AIDS Strategy for the United States: Updated to 2020. This is the first update of the strategy since it was initially released in 2010. Designed to look ahead to 2020, the update includes revised steps and recommendations to meet the strategy goals.   The following resources from AIDS.gov offer more information on the updated strategy: National HIV/AIDS Strategy: Updated to 2020  Infographic: What You Need To Know Infographic: 5 Major Changes Since 2010 (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Pre...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 31, 2015 Category: Infectious Diseases Source Type: news

HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Releases Statement Regarding the START and TEMPRANO Trial Results
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents has released a statement announcing a change in the rating of the Panel’s recommendation on initiation of antiretroviral therapy (ART) based on the recently published results from the START and TEMPRANO trials. Both of these randomized controlled trials demonstrated greater clinical benefits when ART is initiated in asymptomatic HIV-infected patients who started on ART at CD4 counts>500 cells/mm^3 instead of waiting until CD4 counts decline. Based on these results, the Panel’s recommendation remains the same, that ART is recommended for al...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 28, 2015 Category: Infectious Diseases Source Type: news

CDC Updates Slide Set on the HIV Care Continuum
The Centers for Disease Control and Prevention (CDC) recently updated its HIV Care Continuum for the United States and Puerto Rico slide set. The continuum traces the steps in HIV care from diagnosis to successful treatment with antiretroviral drugs. The slide set describes the statistical methods CDC uses to monitor the continuum and includes graphs depicting nationwide progress on continuum-related goals. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 17, 2015 Category: Infectious Diseases Source Type: news

AIDSinfo Drug App Provides Easy Access to HIV-Related Drug Information
The free AIDSinfo Drug App for iOS and Android devices offers easy access to information on more than 100 HIV-related approved and investigational drugs. The information, pulled from the AIDSinfo Drug Database, includes FDA drug labels for health professionals and plain language drug summaries in English and Spanish for consumers. The app also includes additional features allowing users to bookmark drugs, make notes, or set medication reminder alarms.   To ensure that the drug information is always current, the app updates automatically when connected to a wireless or cellular data network. In addition, the app w...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 17, 2015 Category: Infectious Diseases Source Type: news

National Library of Medicine Announces Solicitation of Quotations for the 2015 HIV/AIDS Community Information Outreach Projects
The National Library of Medicine (NLM) is pleased to announce the solicitation of quotations from organizations and libraries to design and conduct projects for improving HIV/AIDS information access for patients and the affected community as well as their caregivers and the general public. Patients and the affected community need access to the most up-to-date and accurate health information to effectively manage and make informed decisions about their health. Health care providers and health educators also need access to the most current information to provide the highest quality of care. NLM is committed to assisting orga...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 2, 2015 Category: Infectious Diseases Source Type: news

News from NIAID
June 22, 2015: NIH-Led Team Advances HIV Vaccine Design with Specially Shaped Protein   June 18, 2015: NIAID-Funded HIV Vaccine Research Generates Key Antibodies in Animal Models   (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 2, 2015 Category: Infectious Diseases Source Type: news

FDA Updates Kaletra Labeling
"The Kaletra (lopinavir/ritonavir) product labeling was updated to include drug-drug interaction information with etravirine, rilpivirine and simeprevir and to update the Use in Specific Populations, Pediatric Use subsection with information from a clinical trial that investigated the use of a once daily dosing regimen."   The updated labeling will be available soon at the FDA website.   More information is available: FDA: Press release AIDSinfo: Patient fact sheet on Kaletra (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. D...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 2, 2015 Category: Infectious Diseases Source Type: news

National Library of Medicine Announces Solicitation of Quotations for the 2015 HIV/AIDS Community Information Outreach Projects
The National Library of Medicine (NLM) is pleased to announce the solicitation of quotations from organizations and libraries to design and conduct projects for improving HIV/AIDS information access for patients and the affected community as well as their caregivers and the general public. Patients and the affected community need access to the most up-to-date and accurate health information to effectively manage and make informed decisions about their health. Health care providers and health educators also need access to the most current information to provide the highest quality of care. NLM is committed to assisting orga...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - June 19, 2015 Category: Infectious Diseases Source Type: news

June 27 is National HIV Testing Day
Plan to participate in National HIV Testing Day on June 27! The annual observance is a time to promote HIV testing—one of the best tools for HIV prevention. The Centers for Disease Control and Prevention (CDC) recommends that everyone between the ages of 13 and 64 get tested for HIV at least once as part of routine health care. Some people with risk factors for HIV should get tested more often.  Visit our National HIV Testing Day webpage [en español] to learn more about the observance and to find information and resources about HIV testing. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - June 19, 2015 Category: Infectious Diseases Source Type: news